Nuvation Bio (NUVB) Shares Outstanding (2020 - 2026)
Nuvation Bio (NUVB) posted quarterly Shares Outstanding (Entity) of $347332.0 for Q1 2026, up 2.58% year-over-year from $338612.0 in Q1 2025, and up 1.7% quarter-over-quarter from $341541.0 in Q4 2025.
Nuvation Bio (NUVB) Shares Outstanding (2020 - 2026) Analysis & Trends
Nuvation Bio (NUVB) has reported Shares Outstanding (Entity) for 7 consecutive years, with $347332.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 2.58% year-over-year to $347332.0; the TTM figure through Mar 2026 stood at $347332.0 (up 2.58% YoY), while the FY2025 annual figure was $341541.0, up 27.07% from the prior year.
- Shares Outstanding (Entity) grew to $347332.0 in Q1 2026 per NUVB's latest filing, from $341541.0 in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $347332.0 in Q1 2026 and bottomed at $213411.0 in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $262187.4 across 5 years, with a median of $219048.0 in 2024.
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) sank 99.9% — and 2025, when it soared 54.58%.
- Nuvation Bio's Shares Outstanding (Entity) stood at $216721.0 in 2022, then increased by 1.0% to $218880.0 in 2023, then advanced by 22.79% to $268772.0 in 2024, then rose by 27.07% to $341541.0 in 2025, then rose by 1.7% to $347332.0 in 2026.
- Business Quant data shows NUVB's Shares Outstanding (Entity) at $347332.0 in Q1 2026, $341541.0 in Q4 2025, and $342393.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Nuvation Bio | 2.16 Bn | 2.16 Bn | 30.78 Mn | 348.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 348,770.00 |
| Mar 31, 2026 | 347,332.00 |
| Dec 31, 2025 | 341,541.00 |
| Sep 30, 2025 | 342,393.00 |
| Jun 30, 2025 | 340,746.00 |
| Mar 31, 2025 | 338,612.00 |
| Dec 31, 2024 | 268,772.00 |
| Sep 30, 2024 | 273,565.00 |
| Jun 30, 2024 | 244,738.00 |
| Mar 31, 2024 | 219,048.00 |
| Dec 31, 2023 | 218,880.00 |
| Sep 30, 2023 | 218,935.00 |
| Jun 30, 2023 | 218,848.00 |
| Mar 31, 2023 | 218,741.00 |
| Dec 31, 2022 | 216,721.00 |
| Sep 30, 2022 | 218,300.00 |
| Jun 30, 2022 | 216,603.00 |
| Mar 31, 2022 | 213,411.00 |
| Dec 31, 2021 | 197.89 Mn |
| Sep 30, 2021 | 207,101.00 |